The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study — Aristotelis Bamias (2018) | RDL Network
Mara Persano, M. Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, F. Piscaglia, Massimo Iavarone, Emiliano Tamburini, Giuseppe Cabibbo, Marianna Silletta, Stefano Cascinu, Mario Scartozzi, A. Casadei Gardini
Aristotle Bamias, Lia A. Moulopoulos, Aggelos Koutras, Gerasimos Aravantinos, George Fountzilas, D. Pectasides, Efstathios Kastritis, D. Gika, Dimosthenis Skarlos, Helena Linardou, Haralabos P. Kalofonos, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.